XML 39 R28.htm IDEA: XBRL DOCUMENT v3.22.2
BUSINESS SEGMENT INFORMATION (Tables)
 6 Months Ended
Jun. 30, 2022
Segment Reporting [Abstract]  
Summary of Segment Reporting Information by Segment The following table is a summary of segment information for the three and six months ended June 30, 2022 and 2021. Segment asset information is not presented since it is not used by the CODM at the operating segment level. Operating earnings (loss) of each segment represents net revenues less directly identifiable expenses to arrive at operating income (loss) for the segment. General corporate activities included in the table below are comprised of general management and administrative corporate expenses, amortization and impairment of intangible assets and other operating income and expenses,
net of certain general corporate activity costs that are allocated to the DIS and DS businesses. The accounting policies of the segments are the same as those of the Company as set forth in Note 2 to the audited consolidated financial statements contained in the Company’s 2021 Annual Report on Form 10-K and Note 2 to the interim unaudited consolidated financial statements.
Three Months Ended June 30,Six Months Ended June 30,
2022202120222021
Net revenues:    
DIS business$2,384 $2,474 $4,925 $5,117 
All other operating segments69 76 139 153 
Total net revenues $2,453 $2,550 $5,064 $5,270 
Operating earnings (loss):    
DIS business$442 $601 $1,004 $1,313 
All other operating segments6 9 13 18 
General corporate activities(60)(77)(116)(138)
Total operating income388 533 901 1,193 
Non-operating (expense) income, net(65)284 (126)250 
Income before income taxes and equity in earnings of equity method investees323 817 775 1,443 
Income tax expense(77)(177)(187)(330)
Equity in earnings of equity method investees, net of taxes4 10 35 27 
Net income250 650 623 1,140 
Less: Net income attributable to noncontrolling interests16 19 34 40 
Net income attributable to Quest Diagnostics$234 $631 $589 $1,100 
Schedule of Revenues by Major Service Net revenues by major service were as follows:
Three Months Ended June 30,Six Months Ended June 30,
2022202120222021
Routine clinical testing and other services$1,098 $1,150 $2,164 $2,182 
COVID-19 testing services355 511 954 1,339 
Gene-based and esoteric (including advanced diagnostics) testing services787 673 1,526 1,326 
Anatomic pathology testing services144 140 281 270 
All other69 76 139 153 
Total net revenues$2,453 $2,550 $5,064 $5,270